These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36026503)

  • 1. PRC1-independent binding and activity of RYBP on the KSHV genome during de novo infection.
    Lee SC; Toth Z
    PLoS Pathog; 2022 Aug; 18(8):e1010801. PubMed ID: 36026503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection.
    Toth Z; Papp B; Brulois K; Choi YJ; Gao SJ; Jung JU
    PLoS Pathog; 2016 Sep; 12(9):e1005878. PubMed ID: 27606464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection.
    Toth Z; Brulois K; Lee HR; Izumiya Y; Tepper C; Kung HJ; Jung JU
    PLoS Pathog; 2013; 9(12):e1003813. PubMed ID: 24367262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
    Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
    PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic analysis of KSHV latent and lytic genomes.
    Toth Z; Maglinte DT; Lee SH; Lee HR; Wong LY; Brulois KF; Lee S; Buckley JD; Laird PW; Marquez VE; Jung JU
    PLoS Pathog; 2010 Jul; 6(7):e1001013. PubMed ID: 20661424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
    Li Q; He M; Zhou F; Ye F; Gao SJ
    J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the lytic cycle of Kaposi's sarcoma-associated herpesvirus by cohesin factors following de novo infection.
    Toth Z; Smindak RJ; Papp B
    Virology; 2017 Dec; 512():25-33. PubMed ID: 28898712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
    Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
    Purushothaman P; Thakker S; Verma SC
    J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells.
    Jha HC; Lu J; Verma SC; Banerjee S; Mehta D; Robertson ES
    mBio; 2014 Dec; 5(6):. PubMed ID: 25516617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative epigenome analysis of gammaherpesviruses suggests cis-acting sequence features as critical mediators of rapid polycomb recruitment.
    Günther T; Fröhlich J; Herrde C; Ohno S; Burkhardt L; Adler H; Grundhoff A
    PLoS Pathog; 2019 Oct; 15(10):e1007838. PubMed ID: 31671162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZIC2 Is Essential for Maintenance of Latency and Is a Target of an Immediate Early Protein during Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
    Lyu Y; Nakano K; Davis RR; Tepper CG; Campbell M; Izumiya Y
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression.
    Toth Z; Brulois KF; Wong LY; Lee HR; Chung B; Jung JU
    J Virol; 2012 Sep; 86(18):9696-707. PubMed ID: 22740393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3.
    Tavares L; Dimitrova E; Oxley D; Webster J; Poot R; Demmers J; Bezstarosti K; Taylor S; Ura H; Koide H; Wutz A; Vidal M; Elderkin S; Brockdorff N
    Cell; 2012 Feb; 148(4):664-78. PubMed ID: 22325148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia and HIF-1α promote lytic
    Lee S-C; Naik NG; Tombácz D; Gulyás G; Kakuk B; Boldogkői Z; Hall K; Papp B; Boulant S; Toth Z
    J Virol; 2023 Nov; 97(11):e0097223. PubMed ID: 37909728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
    Li D; Mosbruger T; Verma D; Swaminathan S
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDM2B Overexpression Facilitates Lytic
    Naik NG; Lee SC; Alonso JD; Toth Z
    J Virol; 2021 May; 95(11):. PubMed ID: 33692209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.